HIV Haemophilia Litigation

http://dbpedia.org/resource/HIV_Haemophilia_Litigation

The HIV Haemophilia Litigation [1990] 41 BMLR 171, [1990] 140 NLJR 1349 (CA), [1989] E N. 2111, also known as AMcG002, and HHL, was a legal claim by 962 plaintiffs, mainly haemophiliacs (but also their wives, partners and children), who were infected with HIV as a result of having been treated with blood products in the late 1970s and early 1980s. The first central defendants were the then Department of Health, with other defendants being the Licensing Authority of the time, (MCA), the CSM (the Committee on the Safety of Medicines), the CBLA (Central Blood Laboratories Authority), and the regional health authorities of England and Wales. In total, there were 220 defendants in the action. rdf:langString
rdf:langString HIV Haemophilia Litigation
rdf:langString HIV Haemophilia Litigation
xsd:integer 69956573
xsd:integer 1102391488
xsd:integer 1
rdf:langString center
rdf:langString
rdf:langString [1989] E N. 2111
rdf:langString [1990] 140 NLJR 1349
rdf:langString [1990] 41 BMLR 171
rdf:langString [1990] EWCA Civ J0920-1
rdf:langString AMcG002 v Central Birmingham Health Authority ,...
rdf:langString
rdf:langString AIDS
rdf:langString Blood products
rdf:langString HIV
rdf:langString Haemophilia
rdf:langString Negligence
rdf:langString
rdf:langString Tort
rdf:langString Breach of statutory duty
rdf:langString Class action
rdf:langString Contaminated blood
rdf:langString No one could doubt the sincerity of the efforts of those in the Department to protect and to assist the plaintiffs as patients in the National Health Service, but on the pleaded case grave errors of judgment were made. Even if there was no grave error of judgment it appears to be not in dispute that there was in fact a failure to protect the plaintiffs from the danger of using blood products, whether imported or supplied in this country, which were infected.
xsd:gMonthDay --09-20
<perCent> 85.0
rdf:langString The HIV Haemophilia Litigation [1990] 41 BMLR 171, [1990] 140 NLJR 1349 (CA), [1989] E N. 2111, also known as AMcG002, and HHL, was a legal claim by 962 plaintiffs, mainly haemophiliacs (but also their wives, partners and children), who were infected with HIV as a result of having been treated with blood products in the late 1970s and early 1980s. The first central defendants were the then Department of Health, with other defendants being the Licensing Authority of the time, (MCA), the CSM (the Committee on the Safety of Medicines), the CBLA (Central Blood Laboratories Authority), and the regional health authorities of England and Wales. In total, there were 220 defendants in the action. The litigation commenced around April 1989 and by 7 July 1989, at least 300 plaintiffs had joined the action. Within four months another 300 haemophiliacs had joined the action, however, by this time, (November 1989) 163 haemophiliacs had already developed full-blown AIDS and 107 had died. There was an initial deadline of 2 February 1990 imposed, however this was extended in order to permit 200 haemophiliac children to sign up to the action.
xsd:date 1990-09-20
xsd:integer 3
xsd:nonNegativeInteger 35598

data from the linked data cloud